Pancreatic cancer trials in Belgium

In Belgium 35 Also abroad 1096

35 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 2/3Not yet taking people in Belgium
A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer
Where
Antwerp, Ghent
Age
18 years and over
People
95 worldwide
Run by
ElmediX
See details and how to joinNCT07711067
Phase 1/2Taking people
A phase 1/2a, first-in-human, open-label, dose-escalating study with a safety expansion cohort to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary anti-tumour activity of TAX2 in patients with relapsed/refractory advanced/metastatic solid tumours
Where
Anderlecht, Gent
Age
18 years and over
People
48 worldwide
Run by
Apmonia Therapeutics
See details and how to join2025-521164-36-00
Phase 1Taking people
Phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-NNS309 in patients with pancreatic, lung, breast and colorectal cancers.
Where
Anderlecht
Age
18 years and over
People
76 worldwide
Run by
Novartis Pharma AG
See details and how to join2023-510356-23-00
No phaseTaking people
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Where
Brussels
Age
18 years and over
People
8,000 worldwide
Run by
UMC Utrecht
See details and how to joinNCT04075305
Phase 1/2Taking people
Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Where
Brussels, Ghent
Age
18 years and over
People
126 worldwide
Run by
Maastricht University Medical Center
See details and how to joinNCT04954599
No phaseTaking people
Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma
Where
Brasschaat, Bruges, Edegem, Genk, Hasselt, Kortrijk, Roeselare, Turnhout, Wilrijk
Age
18 years and over
People
160
Run by
Cancer Research Antwerp
See details and how to joinNCT06691425
No phaseTaking people
Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial)
Where
Dendermonde, Eeklo, Ghent, Oudenaarde, Sint-Niklaas
Age
18 years and over
People
45 worldwide
Run by
University Hospital, Ghent
See details and how to joinNCT05298722
Phase 2/3Taking people
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
Where
Aalst, Bonheiden, Charleroi, Gent, Kortrijk, La Louvière, Leuven, Libramont-Chevigny, Liège, Sint-Lambrechts-Woluwe, Yvoir
Age
18 years and over
People
600 worldwide
Run by
Panbela Therapeutics, Inc.
See details and how to joinNCT05254171 · EU 2024-514714-12-00
No phaseTaking people
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
Where
Anderlecht, Ghent, Wilrijk
Age
18 years and over
People
200 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04498767
Phase 2Taking people
Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma
Where
Anderlecht, Antwerp, Brugge, Brussels, Edegem, Gent, Jette, Kortrijk, La Louvière, Liège, Mons, Namur, Roeselare, Sint-Lambrechts-Woluwe, Yvoir
Age
18 years and over
People
256
Run by
Erasme University Hospital
See details and how to joinNCT05083247 · EU 2022-501181-22-01